American Pharmaceutical News In Review

View online

Forward to a friend | Facebook | Twitter

March 09, 2022

Newsletter Sponsor

Proprietary Nanotechnologies

Ascendia Pharmaceuticals is a specialty CDMO that has developed three proprietary nanotechnologies for all sterile and non-sterile biologics and small molecule formulations. NanoSol^®, EmulSol^®, and AmorSol^® are used to deliver sophisticated formulations to enhance bioavailability and solubility. The unique dosage forms created by Ascendia can be administered orally, topically, injection, ophthalmic, inhalation, and LAI.

	Industry News

Harpoon Therapeutics Granted Orphan Drug Designation for HPN328 for Treatment of Small Cell Lung Cancer
Harpoon Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Orphan ... read more »

Amneal Enters U.S. Biosimilars Market with Approval of RELEUKOTM
Amneal Pharmaceuticals, Inc. announced the FDA has approved the Biologics License Application (BLA) ... read more »

Novo Holdings Portfolio Company Syndesi Therapeutics acquired by AbbVie
Novo Holdings, an international life sciences investor, announced that its portfolio company Syndesi... read more »

Helsinn Group and BridgeBio Pharma to Develop, Manufacture and Commercialize Infigratinib in the U.S.
Helsinn Group and BridgeBio Pharma announced an update to their existing strategic collaboration to ... read more »

	Infographic

Make the Switch to Automated At-line Testing for Mycoplasma: Four compelling reasons to upgrade now
Make the Switch to Automated At-line Testing for Mycoplasma
Fully automated PCR systems have been introduced into the market and offer several improvements over traditional PCR-based methods and can be used to ... read more »

	Featured Articles

Purification Strategies for Recombinant Therapeutic Proteins Many biopharmaceuticals are recombinant proteins obtained by biotechnological processes. In various steps of the pharmaceutical value chain, from drug... read more »

An Interview with Kenneth Laderman, PhD. Director of Manufacturing, Eurofins Advantar Laboratories, Inc Eurofins BioPharma Product Testing highlights how it helps clients in the bio/pharmaceutical industry overcome challenges in sterile fill finish ... read more »

	Featured Video

On-Demand Webinar: Viral Control in Pharmaceutical Processing
This webinar discusses the essential elements of control, testing, and remediation and it includes a spotlight on the maim viruses of concern. watch »

On-Demand Webinar: Development and Validation of a Platform Assay Method Using Variable Pathlength Technology for Oligonucleotide Drug Products
This webinar will share Ionis’ experience with developing and validating a platform SoloVPE® in-process assay method for GMP manufacturing of ... watch »

	Featured Products

Luminata Product Development Software
read more »

	Featured Whitepaper

Microbiological Quality of Non-sterile Products: Culture Media for Compendial Methods
High quality harmonized USP <61> & <62> compliant media is key to successful non-sterile release and incoming testing of materials that need to be free of specified and objectionable microorganisms. Download ... read more »

Whitepaper: The Benefits of Using a DNA Sequencing Method for Microbial Identification
Given the highly regulated nature of the pharmaceutical and medical device industries, quality control of processes and products requires the rapid and accurate identification of microbial ... read more »

	Events

Microscopy & Microanalysis 2022
Portland, OR – 07/31/2022
Portland provides an ideal summer backdrop for what promises to be another stellar M&M meeting! The Pacific Northwest region is a vacationer's dream, ... event details »

Drug Discovery Chemistry
Hilton Bayfront – 04/18/2022
Focused on discovery and optimization challenges of small molecule drug candidates, Drug Discovery Chemistry is a dynamic in-person and online event ... event details »

This information is being brought to you because you are a subscriber to
American Pharmaceutical Review. To ensure delivery to your inbox,
please add newsletters@americanpharmaceuticalreview.com to your address book.

Manage your Subscription | Unsubscribe | Contact American Pharmaceutical Review

American Pharmaceutical Review
164 Townsend St. Unit 2
San Francisco, CA 94107 USA